LONG BEACH, N.Y., March 31 /PRNewswire-FirstCall/ — Chem Rx Corporation
(OTC Bulletin Board: PMQC, PMQCU, PMQCW), a leading provider of institutional
pharmacy services, announced today that it has postponed its conference call
to review 2007 financial results and discuss 2008 outlook that was originally
scheduled for April 1, 2008 at 8:30 a.m. ET. Additional details about the
timing of the 2007 financial results press release and corresponding
conference call will be forthcoming shortly.
About Chem Rx Corporation
Founded more than 40 years ago, Chem Rx Corporation is a leading provider
of institutional pharmacy services in the New York City metropolitan area, as
well as parts of New Jersey, upstate New York, and Pennsylvania. Chem Rx’s
client base includes skilled nursing facilities and a wide range of other
long-term care facilities. Through its services, Chem Rx provides more than
65,000 institutional residents with prescription and non-prescription drugs,
intravenous medications, durable medical equipment items and surgical
supplies. Chem Rx’s website address is www.chemrx.net.
Forward Looking Statements
This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Forward-looking
statements are statements that are not historical facts. Such forward-looking
statements are based upon the current beliefs and expectations of Chem Rx’s
management and are subject to risks and uncertainties that could cause actual
results to differ from the forward-looking statements. The following factors,
among others, could cause actual results to differ from those set forth in the
forward-looking statements: compliance with government regulations; changes
in legislation or regulatory environments; requirements or changes adversely
affecting the health care industry, including changes in Medicare
reimbursement policies; fluctuations in customer demand; management of rapid
growth; intensity of competition; timing, approval and market acceptance of
new product introductions and institutional pharmacy locations; general
economic conditions; geopolitical events and regulatory changes, as well as
other relevant risks detailed in Chem Rx’s filings with the Securities and
Exchange Commission. The information set forth herein should be read in light
of such risks. Chem Rx Corporation does not assume any obligation to update
the information contained in this press release.
Contacts:
Steven C. Silva
President and Chief Operating Officer
Chem Rx Corporation
516-889-8770
The Ruth Group
Investor Relations
Stephanie Carrington / Jared Hoffman
(646) 536-7017 / 7013
scarrington@theruthgroup.com
jhoffman@theruthgroup.com
SOURCE Chem Rx Corporation